Skip to main content
Home
  • The Network
    • Membership
    • Who we are
    • Make the most of our services
    • Cambridge Cluster
    • Cambridge NeuroWorks
    • FAQ
  • Companies
    • Member directory
  • News
    • News listing
    • Blog
  • Events
    • All events
    • Cambridge Network events
    • Advertise your event
    • Boost your event
    • Sponsorship
  • Learning
    • Training courses
    • In-house courses
    • Coaching services
    • Graduate scheme
    • Consultancy services
    • Peer groups
    • Learning FAQ
  • Jobs
    • Jobs listing
    • Recruitment Packages
    • Advertise your vacancies
    • Connect with future talent
    • Boost your job
    • Tips for finding a job
More
    • Contact us
    • Join the network
    • Log in
    • The Network
      • Membership
      • Who we are
      • Make the most of our services
      • Cambridge Cluster
      • Cambridge NeuroWorks
      • FAQ
    • Companies
      • Member directory
    • News
      • News listing
      • Blog
    • Events
      • All events
      • Cambridge Network events
      • Advertise your event
      • Boost your event
      • Sponsorship
    • Learning
      • Training courses
      • In-house courses
      • Coaching services
      • Graduate scheme
      • Consultancy services
      • Peer groups
      • Learning FAQ
    • Jobs
      • Jobs listing
      • Recruitment Packages
      • Advertise your vacancies
      • Connect with future talent
      • Boost your job
      • Tips for finding a job

    Breadcrumb

    1. Home
    2. Research

    Research

    Qkine cell therapy grade vial and information card
    8 October 2025

    Qkine launches cell therapy grade recombinant proteins to support next-generation therapies

    Cambridge, UK – Qkine, Ltd., a specialist bioactive protein manufacturer with its core technology developed at the University of Cambridge, today announced the launch of its Cell Therapy Grade proteins, engineered to support the stringent requirements of cell therapy research, process d...

    26 August 2026

    Webinar: Overexpression of LIGHT on cancer cells facilitates T-cell cross-priming

    Join the Functional Genomics Screening Laboratory (FGSL) team as we welcome Dr Lorena Boquete Vilariño for this special webinar. ...

    granite 5 logo
    8 October 2025

    Granite 5 wins international award for Vitae website

    We’re delighted to share that Granite 5 has been recognised at the 16th Web Excellence Awards, winning for our work on the new Vitae website. The Web Excellence Awards celebrate the very best of the web, honouring creativity, innovation, and impact in digital design and marketing. This...

    CJ & L Consultancy Ltd
    1 October 2025

    CJ & L Consultancy to launch ‘Rent an eQMS’ – A ready-to-use Compliance Solution on 1st November 2025

    Start-ups and small businesses can now access a fully functioning Electronic Quality Management System (eQMS) without the heavy investment of building one in-house. Designed to meet ISO 9001, 13485, 27001, and 45001, our eQMS is adaptable, secure, and available immediately — so you can...

    Man sat at office desk
    1 October 2025

    91% of SMEs rate Government support as poor or very poor, survey by the Association of Practising Accountants finds

    91% of owner managed businesses rate Government support to the SME sector as either poor or very poor – up from 83% in 2024 and 77% in 2023 while 64% of these businesses are unlikely to make significant capital investment in the next 12 months.  These are two of the key findings of...

    26 August 2026

    Frontiers in Stem Cell Innovation 2026

    The Frontiers in Stem Cell Innovation Conference 2026 will bring together leading academic and industry expertise in stem cell research to explore the breakthrough technologies and translational developments that are transforming drug discovery and therapeutic development. ...

    Dr Yang Wang (left) and Dr Peter Rugg-Gunn (right) shown over a data analysis plot from the scMTR-seq technique (Wang et al. 2025. Figure 3, E - Clustered smooth heatmaps showing gene expression and associated histone modification levels at their promoters and gene bodies).
    30 September 2025

    Prizes for team behind game-changing multi-omics method to decode gene regulation

    Babraham Institute researchers have developed a new multi-omics method enabling the profiling of multiple histone modifications and gene expression in single cells. Lead researchers, Peter Rugg-Gunn and Yang Wang, received the Top Rising Star award by BioCentury Grand Rounds in recognit...

    fibroblast single cell
    25 September 2025

    Universal drug target potential in scaffolding cells found across the body

    Scientists have mapped underappreciated scaffolding cells in skin, known as fibroblasts. They show for the first time how fibroblasts go ‘rogue’ in many different diseases affecting multiple organs – from acne and psoriasis, to rheumatoid arthritis and inflammatory bowel disease. ...

    IDTechEx Market Report: Next-Generation MEMS 2026-2036
    4 November 2025

    New IDTechEx Market Report: Next-generation MEMS 2026-2036

    Microelectromechanical systems (MEMS) is a US$15 billion industry that has grown and reached maturity in many sectors, but what are the technologies on the horizon that could be the next big leap forward for MEMS? ...

    New IDTechEx Market Report: Quantum Sensors Market 2026-2046
    14 October 2025

    New IDTechEx Market Report: Quantum Sensors Market 2026-2046

    This new IDTechEx report characterizes the quantum sensor market, key technologies, and players. Coverage across 20 quantum sensing technology areas, with applications of quantum sensors in electric vehicles, navigation, medical imaging, and quantum computing with market forecasts from ...

    Pagination

    • First page «
    • Previous page ‹‹
    • …
    • Page 24
    • Page 25
    • Current page 26
    • Page 27
    • Page 28
    • …
    • Next page ››
    • Last page »
    Receive our newsletter

    Footer menu

    • Terms & Conditions
    • Disclaimer
    • Privacy
    • Cookies
    • FAQ

    Cambridge Network Limited is a company registered in England under company No. 3400152

    The Hauser Forum, 3 Charles Babbage Road, Cambridge, CB3 0GT

    Email: [email protected], Tel: 01223 746801

    © 2026 Cambridge Network. All Rights Reserved.

    Website by KISS